Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Inflammatory Bowel Diseases

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 16 articles: HTML format

Single Articles

October 2026
1. UHLIG HH, Hambleton S, Travis S
   Interleukin-10 Autoantibodies in Inflammatory Bowel Disease. Reply.
   N Engl J Med. 2026;395:1459.
   PubMed    
   
   
   
2. BAI X, Xu C, Yang H
   Interleukin-10 Autoantibodies in Inflammatory Bowel Disease.
   N Engl J Med. 2026;395:1458-1459.
   PubMed    
   
   
   
3. KUCUK H, Erden A, Tufan A
   Interleukin-10 Autoantibodies in Inflammatory Bowel Disease.
   N Engl J Med. 2026;395:1458.
   PubMed    
   
   
   
4. ANTONIOLI L
   Interleukin-10 Autoantibodies in Inflammatory Bowel Disease.
   N Engl J Med. 2026;395:1457-1458.
   PubMed    
   
   
   June 2026
5. GHARAHDAGHI N, Yeh PJ, Ceron-Gutierrez L, Griffin H, et al
   Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease.
   N Engl J Med. 2026;394:2212-2222.
   PubMed     Abstract available
   
   
   October 2025
6. RAHIMOV F, Jacobs BM, Lee JS, Mahi NA, et al
   Common Diseases in Clinical Cohorts - Not Always What They Seem.
   N Engl J Med. 2025;393:1589-1598.
   PubMed     Abstract available
   
   
   September 2025
7. MULLER F, Atreya R, Volkl S, Aigner M, et al
   CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis.
   N Engl J Med. 2025;393:1239-1241.
   PubMed    
   
   
   September 2024
8. SANDS BE, Feagan BG, Peyrin-Biroulet L, Danese S, et al
   Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.
   N Engl J Med. 2024;391:1119-1129.
   PubMed     Abstract available
   
   
   August 2024
9. GRIFFIN H, Ceron-Gutierrez L, Gharahdaghi N, Ebrahimi S, et al
   Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.
   N Engl J Med. 2024;391:434-441.
   PubMed     Abstract available
   
   
   July 2024
10. ABRAHAM C
    Interleukin-23 p19 and Interleukin-12 p40, Head-to-Head, against Gut Inflammation.
    N Engl J Med. 2024;391:275-277.
    PubMed    
    
    
    
11. PEYRIN-BIROULET L, Chapman JC, Colombel JF, Caprioli F, et al
    Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
    N Engl J Med. 2024;391:213-223.
    PubMed     Abstract available
    
    
    August 2023
12. 
    Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2023;389:772.
    PubMed    
    
    
    June 2023
13. D'HAENS G, Dubinsky M, Kobayashi T, Irving PM, et al
    Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2023;388:2444-2455.
    PubMed     Abstract available
    
    
    May 2023
14. ABREU MT
    JAK1 Inhibition to Treat Crohn's Disease.
    N Engl J Med. 2023;388:2005-2009.
    PubMed    
    
    
    
15. LOFTUS EV JR, Panes J, Lacerda AP, Peyrin-Biroulet L, et al
    Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
    N Engl J Med. 2023;388:1966-1980.
    PubMed     Abstract available
    
    
    March 2023
16. TRAVIS S, Silverberg MS, Danese S, Gionchetti P, et al
    Vedolizumab for the Treatment of Chronic Pouchitis.
    N Engl J Med. 2023;388:1191-1200.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum